BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 41 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $446,000 | -9.0% | 430,000 | 0.0% | 0.33% | -27.4% |
| Q2 2019 | $490,000 | -2.6% | 430,000 | -2.3% | 0.46% | +43.7% |
| Q1 2019 | $503,000 | -1.9% | 440,000 | -4.3% | 0.32% | -20.3% |
| Q4 2018 | $513,000 | -12.3% | 460,000 | -5.2% | 0.40% | +1.5% |
| Q3 2018 | $585,000 | -9.6% | 485,000 | -11.0% | 0.39% | +12.0% |
| Q2 2018 | $647,000 | +165.2% | 545,000 | +147.7% | 0.35% | +123.6% |
| Q1 2018 | $244,000 | +577.8% | 220,000 | +633.3% | 0.16% | +528.0% |
| Q4 2017 | $36,000 | – | 30,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 5,950,000 | $6,146,000 | 4.56% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 37,943,000 | $39,192,000 | 0.73% |
| Sonora Investment Management, LLC | 4,670,000 | $4,791,000 | 0.50% |
| MIZUHO SECURITIES USA LLC | 5,900,000 | $6,096,000 | 0.36% |
| IRON Financial LLC | 430,000 | $446,000 | 0.33% |
| RWC Asset Management LLP | 7,300,000 | $7,528,000 | 0.32% |
| Calamos Advisors LLC | 49,525,000 | $51,243,000 | 0.28% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 5,777,000 | $5,977,000 | 0.24% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,721,000 | $5,896,000 | 0.18% |
| Calamos Wealth Management LLC | 1,240,000 | $1,283,000 | 0.17% |